Literature DB >> 12619171

Serum lipid levels in psoriasis.

Suleyman Piskin1, Figen Gurkok, Galip Ekuklu, Mustafa Senol.   

Abstract

A predisposition to occlusive vascular diseases has been reported in patients with psoriasis and it has been suggested that some of these patients have some disorders of lipid metabolism. In this study, serum lipid levels were investigated in psoriatic patients to explore to the knowledge of this relationship. One hundred psoriatic patients and 100 non- psoriatic controls were included in the study. Total cholesterol, triglyceride, high-density lipoprotein-cholesterol (HDL-cholesterol), low-density lipoprotein-cholesterol (LDL-cholesterol), and very low-density lipoprotein-cholesterol (VLDL-cholesterol) levels were measured. In patients with psoriasis, total cholesterol and LDL-cholesterol levels were found to be significantly higher than those of controls. No significant differences were found in the other parameters. We concluded that psoriatic patients should be evaluated and followed up for the risk of hyperlipidemia and obstructive vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12619171     DOI: 10.3349/ymj.2003.44.1.24

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  12 in total

Review 1.  Metabolic disorders in patients with psoriasis and psoriatic arthritis.

Authors:  Lotus Mallbris; Christopher T Ritchlin; Mona Ståhle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 2.  Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.

Authors:  Rita V Patel; Michael L Shelling; Srdjan Prodanovich; Daniel G Federman; Robert S Kirsner
Journal:  J Gen Intern Med       Date:  2011-04-07       Impact factor: 5.128

3.  Endometriosis, Psoriasis, and Psoriatic Arthritis: A Prospective Cohort Study.

Authors:  Holly R Harris; Karen Moreno Nascimento Korkes; Tricia Li; Marina Kvaskoff; Eunyoung Cho; Luiz Fernando Carvalho; Abrar A Qureshi; Mauricio Abrao; Stacey A Missmer
Journal:  Am J Epidemiol       Date:  2022-05-20       Impact factor: 5.363

4.  Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies.

Authors:  Saumya Choudhary; Rachana Patel; Dibyabhaba Pradhan; Ravi Deval; Harpreet Singh; George Thomas; Arun Kumar Jain
Journal:  3 Biotech       Date:  2020-02-07       Impact factor: 2.406

Review 5.  Lipid disturbances in psoriasis: an update.

Authors:  Aldona Pietrzak; Anna Michalak-Stoma; Grazyna Chodorowska; Jacek C Szepietowski
Journal:  Mediators Inflamm       Date:  2010-07-20       Impact factor: 4.711

Review 6.  National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

Authors:  Alexa B Kimball; Dafna Gladman; Joel M Gelfand; Kenneth Gordon; Elizabeth J Horn; Neil J Korman; Gretchen Korver; Gerald G Krueger; Bruce E Strober; Mark G Lebwohl
Journal:  J Am Acad Dermatol       Date:  2008-03-04       Impact factor: 11.527

7.  Characterization of the abnormal lipid profile in Chinese patients with psoriasis.

Authors:  Xiaowen Pang; Kai Lin; Wen Liu; Ping Zhang; Sainan Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

8.  Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients.

Authors:  Nilgun Solak Tekin; Ishak Ozel Tekin; Figen Barut; Emine Yilmaz Sipahi
Journal:  Mediators Inflamm       Date:  2006-12-27       Impact factor: 4.711

9.  Dyslipidemia in Psoriasis: A Case Controlled Study.

Authors:  Y C Nakhwa; R Rashmi; K H Basavaraj
Journal:  Int Sch Res Notices       Date:  2014-10-08

10.  Trends in lipid profiles in patients with psoriasis: a population-based analysis.

Authors:  Bharath Manu Akkara Veetil; Eric L Matteson; Hilal Maradit-Kremers; Marian T McEvoy; Cynthia S Crowson
Journal:  BMC Dermatol       Date:  2012-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.